These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9881094)

  • 21. Highly potent cell differentiation-inducing analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological activity of 2-methyl-1,25-dihydroxyvitamin D3 with side-chain modifications.
    Fujishima T; Zhaopeng L; Konno K; Nakagawa K; Okano T; Yamaguchi K; Takayama H
    Bioorg Med Chem; 2001 Feb; 9(2):525-35. PubMed ID: 11249144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
    Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF
    Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New derivative of 1alpha,25-dihydroxy-19-norvitamin D3 with 3'-alkoxypropylidene moiety at C-2: synthesis, biological activity and conformational analysis.
    Glebocka A; Sicinski RR; DeLuca HF
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):25-30. PubMed ID: 15225741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity.
    Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.
    Shimizu M; Miyamoto Y; Kobayashi E; Shimazaki M; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem; 2006 Jun; 14(12):4277-94. PubMed ID: 16503143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Ethyl and 2-ethylidene analogues of 1alpha,25-dihydroxy-19-norvitamin D(3): synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain.
    Sicinski RR; Rotkiewicz P; Kolinski A; Sicinska W; Prahl JM; Smith CM; DeLuca HF
    J Med Chem; 2002 Aug; 45(16):3366-80. PubMed ID: 12139448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions.
    Norman AW; Manchand PS; Uskokovic MR; Okamura WH; Takeuchi JA; Bishop JE; Hisatake JI; Koeffler HP; Peleg S
    J Med Chem; 2000 Jul; 43(14):2719-30. PubMed ID: 10893309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
    Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Uskokovic MR; Brenner RV; Evans SR
    Cancer Res; 1994 Aug; 54(15):4057-64. PubMed ID: 8033137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
    Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diastereotopic and deuterium effects in gemini.
    Maehr H; Rochel N; Lee HJ; Suh N; Uskokovic MR
    J Med Chem; 2013 May; 56(10):3878-88. PubMed ID: 23566225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total synthesis of 25-hydroxy-16,23E-diene vitamin D3 and 1 alpha,25-dihydroxy-16,23E-diene vitamin D3: separation of genomic and nongenomic vitamin D activities.
    Kabat MM; Burger W; Guggino S; Hennessy B; Iacobelli JA; Takeuchi K; Uskoković MR
    Bioorg Med Chem; 1998 Nov; 6(11):2051-9. PubMed ID: 9881096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological activity of (22E,25R)- and (22,25S)-22-dehydro- 1 alpha,25-dihydroxy-26-methylvitamin D3.
    Hara N; Eguchi T; Ikekawa N; Ishizuka S; Sato J
    J Steroid Biochem; 1990 May; 35(6):655-64. PubMed ID: 2163469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and Biological Activity of 2-Methylene Analogues of Calcitriol and Related Compounds.
    Sibilska IK; Szybinski M; Sicinski RR; Plum LA; DeLuca HF
    J Med Chem; 2015 Dec; 58(24):9653-62. PubMed ID: 26574921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of analogues of 1alpha,25-dihydroxyvitamin D3 with biased side chain orientation: methylated des-C,D-homo analogues.
    Gabriëls S; Van Haver D; Vandewalle M; De Clercq P; Verstuyf A; Bouillon R
    Chemistry; 2001 Jan; 7(2):520-32. PubMed ID: 11271538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
    González-Avión XC; Mouriño A; Rochel N; Moras D
    J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New vitamin D3 derivatives with unexpected antiproliferative activity: 1-(hydroxymethyl)-25-hydroxyvitamin D3 homologs.
    Posner GH; Nelson TD; Guyton KZ; Kensler TW
    J Med Chem; 1992 Aug; 35(17):3280-7. PubMed ID: 1324319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and biological evaluation of a 1alpha,25-dihydroxy-19-norvitamin D3 analogue with a frozen A-ring conformation.
    Sicinski RR; Glebocka A; Plum LA; DeLuca HF
    J Med Chem; 2007 Nov; 50(24):6154-64. PubMed ID: 17960924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological characterization of 1alpha,24,25-trihydroxy-2beta-(3-hydroxypropoxy)vitamin D(3) (24-hydroxylated ED-71).
    Hatakeyama S; Kawase A; Uchiyama Y; Maeyama J; Iwabuchi Y; Kubodera N
    Steroids; 2001; 66(3-5):267-76. PubMed ID: 11179734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological activity of novel vitamin D analogues: 24,24-difluoro-25-hydroxy-26,27-dimethylvitamin D3 and 24,24-difluoro-1 alpha,25-dihydroxy-26,27-dimethylvitamin D3.
    Gill HS; Londowski JM; Corradino RA; Zinsmeister AR; Kumar R
    J Med Chem; 1990 Feb; 33(2):480-90. PubMed ID: 2153815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.